Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Underlying metabolic pathways in cancer
Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain
Underlying metabolic pathways in cancer ( Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain )
18 Jul 2012
Highlights of the 22nd EACR meeting and tackling glioblastoma
Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012
Signaling and targeting cellular pathways in leukaemia metabolism
Dr Jing Chen – Emory University School of Medicine, Atlanta, USA
Signaling and targeting cellular pathways in leukaemia metabolism ( Dr Jing Chen – Emory University School of Medicine, Atlanta, USA )
26 Jun 2012
Whole genome sequence analysis for acute lymphoblastic leukaemia
Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA
Whole genome sequence analysis for acute lymphoblastic leukaemia ( Dr Charles Mullighan - St Jude Children's Research Hospital, Memphis, USA )
26 Jun 2012
Use of mesenchymal stromal cells against graft-versus-host disease
Prof Willem Fibbe – Lieden University Medical Center, Holland
Use of mesenchymal stromal cells against graft-versus-host disease (  Prof Willem Fibbe – Lieden University Medical Center, Holland )
26 Jun 2012
Next generation sequencing and the monoclonal structure of multiple myeloma
Dr Niccolo Bolli – University of Cambridge, UK
Next generation sequencing and the monoclonal structure of multiple myeloma ( Dr Niccolo Bolli – University of Cambridge, UK )
26 Jun 2012
Mouse models and proteomics tackling acute lymphoblastic leukaemia
Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland
Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )
25 Jun 2012
Highlights and goals of IMPAKT 2012
Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium
Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
PI3K and the heterogeneity of small tumour breast cancer
Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium
PI3K and the heterogeneity of small tumour breast cancer ( Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
Heterogeneity of tumours and the challenges of biomarker development
Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy
Heterogeneity of tumours and the challenges of biomarker development ( Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy )
17 May 2012
Targeting the cancer genome
Dr Bill Sellers - Novartis Institutes for Biomedical Research, Cambridge, Massac...
Targeting the cancer genome ( Dr Bill Sellers - Novartis Institutes for Biomedical Research, Cambridge, Massachusetts )
13 Apr 2012
Anti-angiogenic agents and cancer stem cells
Dr Max Wicha - University of Michigan, Ann Arbor, USA
Anti-angiogenic agents and cancer stem cells ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )
13 Apr 2012